Dr. Alex Shteynshlyger:
Recent Journal Articles (Peer Reviewed Publications):
Kathy L. Schulman, MA, Karina Berenson, MPH, Ya-Chen (Tina) Shih, PhD, Kathleen A. Foley, PhD,Â Arijit Ganguli, MBA, PhD, Jonas de Souza MD, Alex Shteynshlyuger, MD. “A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report Of The ISPOR Oncology Good Outcomes Research Practices Working Group.” Value in Health V16(4):655-669, June 2013
Shteynshlyuger A, Yu J. “Familial testicular torsion: A meta analysis suggests inheritance.” J Pediatr Urol. 2013 Oct;9(5):683-90.
Shteynshlyuger A, Andriole GL. “Cost Effectiveness of PSA Screening in the US: Extrapolating from the ERSPC Trial”. J. Urology. Vol 185. P828-832: March 2011.
Shteynshlyuger A, Freyle, J. “Familial Testicular Torsion in Three Consecutive Generations of First Degree Relatives.” J Pediatr Urol. 2011 Feb;7(1):86-91
Shteynshlyuger A, Andriole GL. “Prostate cancer: to screen or not to screen?” in Advances and Controversies in Prostate Cancer, An Issue of Urologic Clinics By William K. Oh, James C. Hu Urol Clin North Am. 2010 Feb;37(1):1-9, Review.
Shteynshlyuger A, Kibel AS. Words of Wisdom: Re: Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era European Urology. December 2009 (Vol. 56, Issue 6, Pages 1089-1090)
Shteynshlyuger A, Kibel AS. Counterpoint: Prostate carcinoma treatment for the young patient-The case for radical prostatectomy. Brachytherapy. 2010 Jun 29.
Shteynshlyuger A, Kibel AS. Rebuttal to Dr. Wallner. Brachytherapy. 2010 Jul
Shteynshlyuger A. “The effect of PSA Screening on Quality Adjusted Life Years (QALY): a model based on the population based results from the ERSPC”. Submitted for publication.
Shteynshlyuger A. “Cost effectiveness of radical prostatectomy versus watchful waiting for non-screen detected prostate cancer: extrapolating from the Scandinavian trial” Submitted for publication.
Blute M, Hakimian P, Kashanian J, Shteynshlyuger A, Lee M, Shabsigh R. “Erectile dysfunction and testosterone deficiency.” Front Horm Res. 2009;37:108-22. Review.
Wise GJ, Shteynshlyuger A. How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep. 2006 Jul;7(4):320-8. Review.
Gilbert J. Wise GJ, Shteynshlyuger A. An update on lower urinary tract tuberculosis. Current Prostate Reports. Vol 5 (2): 87-95. June 2007.
Gilbert J. Wise GJ, Shteynshlyuger A. Atypical Infections of the prostate. Current Prostate Reports. 2008, 6 (2): 86-93
Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R. Erectile dysfunction and testosterone deficiency. Front Horm Res. 2009;37:108-22.
Ruben M. Pinkhasov, Alex Shteynshlyuger, Payam Hakimian, Gaius K. Lindsay, David B. Samadi, Ridwan Shabsigh. Are men shortchanged on health? Perspective on life expectancy, morbidity, and mortality in men and women in the United States. Int J Clinical Practice. 2009: Accepted for publication
Shteynshlyuger, A. Characterization of proteins binding to the ßE5 motif of the T cell receptor ß-chain enhancer / (1999). Senior honors thesis–Brandeis University, 1999.
Shteynshlyuger A. and Andriole GL (2011). “Prostate Cancer Screening and Epidemiology” in Spiess P. (Ed.) Essentials and Updates in Urologic Oncology. In publication: Jan 2011.
Alex Shteynshlyuger “Fungal Infections of the Prostate in the Era of Immunocompromise.” New York Academy of Medicine. Urology Section. 2005.
Alex Shteynshlyuger, Aaron H Lay, Feng Gao, Siobhan Sutcliffe, Jason Luly, M’Liss A Hudson, Adam S Kibel, Robert L Grubb, III. “Muscle invasive bladder cancer in the elderly: Does radical cystectomy improve mortality?” Society of Urologic Oncology. Bethesda, MD; Dec 5, 2009. Poster presentation.
Alex Shteynshlyuger. “The effect of PSA Screening on Quality Adjusted Life Years (QALY): a model based on the population based results from the ERSPC”. AUA 2010 (San Francisco, CA June 3-May 29, 2010: Accepted for podium presentation.
Alex Shteynshlyuger, Gerald L Andriole. “Cost Effectiveness of PSA Screening in the US: Extrapolating from the ERSPC Trial.” AUA 2010 (San Francisco, CA June 3-May 29, 2010: Accepted for moderated poster presentation.
Alex Shteynshlyuger. “Cost effectiveness of radical prostatectomy versus watchful waiting for non-screen detected prostate cancer: extrapolating from the Scandinavian trial” ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 15th Annual International Meeting (May 15-19, 2010; Atlanta, GA, USA: Accepted for poster presentation).
Alex Shteynshlyuger, Shaun Grewal, Maria Serrano, Ted Skolarus, Feng Gao, Robert Grubb III, Matthew Katz, Seth Strope, Peter Humphrey, Adam Kibel. “Common Adverse Histopathological Features Are Not Associated With Differential Survival For Patients Undergoing Partial Compared To Radical Nephrectomy For Renal Masses ≤ 7 Cm. AUA South Central Section Annual Meeting. White Sulphur Springs, WV. Sep 22 – 26 2010
- Best Resident Research Paper – Maimonides Scientific Day – March 2007 “Genitourinary tuberculosis as the primary manifestation of infection. A new paradigm of tuberculosis epidemiology.”
- Howard Hughes Fellowship Mini-symposium. August 11, 1998. BrandeisUniversity
- Grand Rounds. “Genitourinary Fistulas.” Sept. 22, 2006. Coney Island Hospital
- NY Academy of Medicine – Urology Section. Chief Resident Debate. March 4, 2009. “Ureteroscopy vs medically expulsive therapy (MET) with tamsulosin for distal ureteral stones.”
Return to the full profile for Dr. Alex Shteynshlyuger